首页> 外文期刊>British Journal of Radiology >Evaluation of adverse reactions to contrast media in the hospital
【24h】

Evaluation of adverse reactions to contrast media in the hospital

机译:评估医院造影媒体的不良反应

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To determine and analyse the characteristics of contrast media adverse reactions (CM-ARs) reported in a hospital. Methods: A retrospective review of CM-ARs from the electronic spontaneous adverse drug reaction (ADR) report system between January 2011 and August 2012 was conducted. CM-ARs were evaluated in terms of causality, severity, preventability and affected organs. Also, agreement and correlation among the tools used to evaluate CM-ARswere analysed. Results: The overall reaction rate was 1.5% (n=286). In total, 269 CM-ARs were identified. For ADR causality, 96.7% (n=260) and 98.5% (n=265) were evaluated as "probable" ADR using the Naranjo probability scale and the World Health Organization-Uppsala Monitoring Centre causality categories, whereas 98.1% (n=264) were evaluated as "certain" with Korean algorithm v. 2. Of these, 91.4% (n=246) were mild in severity and 96.7% (n=260) were unpreventable. Most patients (n=233, 86.7%) could be managed with observation and/or simple treatment. The most frequent reaction (n=383, 79.5%) was dermatological. Spearman's correlation coefficient was 0.667 (p<0.01), and the agreement was 98.1% between the Naranjo scale and the World Health Organization-Uppsala Monitoring Centre categories. No relationship was seen between CM-AR severity and gender or between in- and outpatients. Conclusion: In our study, most CM-ARs were mild and managed with simple treatment. However, as the number of patients undergoing CT procedures continues to increase, it is essential to identify and observe patients at risk for CM-ARs to prevent severe ADRs. Advances in knowledge: Continuous careful review of reporting and treatment protocols of CM-ARs is needed to prevent morbidity and mortality.
机译:目的:确定和分析医院报告造影介质不良反应(CM-ARS)的特征。方法:对2011年1月至2012年1月至2012年8月的电子自发不良药物反应(ADR)报告系统对CM-AR的回顾性审查。根据因果关系,严重程度,预防性和受影响的器官来评估CM-AR。此外,分析了用于评估CM-Arswere的工具之间的协议和相关性。结果:总反应速率为1.5%(n = 286)。总共确定了269cm-AR。对于ADR因果关系,使用Naranjo概率规模和世界卫生组织 - 乌普萨拉监测中心因果关系类别评估96.7%(n = 260)和98.5%(n = 265)作为“可能的”ADR,而98.1%(n = 264 )用韩国算法v.2评估为“某些”。其中,91.4%(n = 246)严重程度轻度,96.7%(n = 260)是不可申请的。大多数患者(n = 233,86.7%)可以通过观察和/或简单的治疗来管理。最常见的反应(n = 383,79.5%)是皮肤病。 Spearman的相关系数为0.667(P <0.01),Naranjo规模与世界卫生组织 - 乌普萨拉监测中心类别之间的协议为98.1%。在CM-AR严重程度和性别之间或内外分裂之间没有看到任何关系。结论:在我们的研究中,大多数cm-ars温和,并以简单的治疗管理。然而,随着所接受CT程序的患者的数量继续增加,必须鉴定和观察患者对CM-AR的风险,以防止严重的ADR。知识进展:不需要仔细审查报告和治疗方案,以防止发病率和死亡率。

著录项

  • 来源
    《British Journal of Radiology》 |2013年第1032期|共1页
  • 作者

    KyungE.-J.; RyuJ.-H.; KimE.-Y.;

  • 作者单位

    College of Pharmacy Chungnam National University Daejeon South Korea;

    Department of Pharmacy St Mary's Hospital Daejeon South Korea;

    College of Pharmacy Chung-Ang University Seoul South Korea;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 放射医学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号